Development of hyperfibrinogenemia in spontaneously hypertensive and hyperlipidemic rats: A potentially useful animal model as a complication of hypertension and hyperlipidemia

Experimental Animals

Volumn 56, Issue 1, 2007, Pages 1-10

  Gomibuchi, Hiroshi ^a   Okazaki, Masako ^a   Iwai, Shinichi ^a   Kumai, Toshio ^b   Kobayashi, Shinichi ^b   Oguchi, Katsuji ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Fibrinogen; Hypercoagulation; mRNA

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANGIOTENSIN III; CHOLESTEROL; FIBRINOGEN; MESSENGER RNA; PLASMINOGEN; PROTHROMBIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE MODEL; FIBRINOGEN DEFECT; FIBRINOLYSIS; HYPERCOAGULABILITY; HYPERFIBRINOGENEMIA; HYPERLIPIDEMIA; HYPERTENSION; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; ANTITHROMBIN III; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; FIBRINOGEN; FIBRINOLYSIS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; PLASMINOGEN; PROTHROMBIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; THROMBOPHILIA;

ANIMALIA; RATTUS;

EID: 33847617000     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.56.1     Document Type: Article

References (32)

1. Abumiya, T., Sakata, T., Enjyoji, K., Kato, H., Kawai, J., Suzuki, T., Masuda, J., Sasaguri, T., and Ogata, J. 2000. Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats? J. Hypertens. 18: 901-909.
2. Amagasa, H., Okazaki, M., Iwai, S., Kumai, T., Kobayashi, S., and Oguchi, K. 2005. Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats. J. Atheroscler. Thromb. 12: 191-198.
3. Cassar, K., Bachoo, P., Ford, I., Greaves, M., and Brittenden, J. 2005. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 29: 171-176.
4. Chinellato, A., Ragazzi, E., Petrelli, L., Paro, M., Mironov, A., and Aliev, G. 1994. Effect of cholesterol-supplemented diet in heritable hyperlipidemic Yoshida rats: functional and morphological characterization of thoracic aorta. Atherosclerosis 106: 51-63.
5. Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D.O., and Collins, R. 2005. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J.A.M.A. 294: 1799-1809.
6. Demarmels Biasiutti, F., Berger, D., Mattel, H.P., Lämmle, B., and Wuillemin, W.A. 2003. Hemostatic risk factors in ischemic stroke. Thromb. Haemost. 90: 1094-1099.
7. Deten, A., Volz, H.C., Briest, W., and Zimmer, H-G. 2002. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc. Res. 55: 329-340.
8. Ernst, E. and Resch, K.L. 1993. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118: 956-963.
9. Ernst, E., Weihmayr, T., Schmid, M., Baumann, M., and Matrai, A. 1986. Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. Atherosclerosis 59: 263-269.
10. Garćia-Donaire, J.A., Nunez, A.G., Segure, J., and Ruilope, L.M. 2004. Cerebrovascular protection and antihypertensive therapy. Curr. Opin. Nephrol. Hypertens. 13: 507-512.
11. Huang, S., Cao, Z., Chung, D.W., and Davie, E.W. 1996. The Role of βγ fly and αγ complexes in the assembly of human fibrinogen. J. Biol. Chem. 271: 27942-27947.
12. Ichino, K., Okazaki, M., Usami, S., and Oguchi, K. 1997. Involvement of enhanced coagulation and fibrinolysis system in induction of atherosclerosis in hyperlipidemic rabbits fed on a high cholesterol diet. In Vivo 11: 115-124.
13. Iwai, S., Okazaki, M., Kiuchi, Y., and Oguchi, K. 1999. Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin. Thromb. Res. 96: 421-426.
14. Jastrzebska, M., Torbus-Lisiecka, B., Pieczul-Mróz, J., CheLstowski, K., and Naruszewicz, M. 1997. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons. Mater. Med. Pol. 29: 3-7.
15. Junker, R., Heinrich, J., Schulte, H., Erren, M., and Assmann, G. 1998. Hemostasis in normotensive and hypertensive men: results of the PROCAM study. J. Hypertens. 16: 917-923.
16. Kant, J.A., Furnace, A.J. Jr., and Saxe, D. 1985. Evolution and organisation of the fibrinogen locus on chromosome 4: gene duplication accompanied by transcription and inversion. Proc. Natl. Acad. Sci. USA 82: 2344-2348.
17. Kannel, W.B. 1997. Influence of fibrinogen on cardiovascular disease. Drugs 54 3: 32-40.
18. Koenig, W. 2003. Fibrin(ogen) in cardiovascular disease: an update. Thromb. Haemost. 89: 601-609.
19. Koenig, W. and Ernst, E. 1992. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 94: 93-107.
20. Kumai, T., Oonuma, S., Matsumoto, N., Takeba, Y., Taniguchi, R., Kamio, K., Miyazu, O., Koitabashi, Y., Sekine, S., Tadokoro, M., and Kobayashi, S. 2004. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia. Life Sci. 74: 2129-2142.
21. Kumai, T., Oonuma, S., Kitaoka, Y., Tadokoro, M., and Kobayashi, S. 2003. Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats. Clin. Exp. Pharmacol. Physiol. 30: 537-544.
22. Lemne, C. and De Faire, U. 1996. Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances. Eur. J. Clin. Invest. 26: 692-697.
23. Maresca, G., Di Blasio, A., Marchioli, R., and Di Minno, G. 1999. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 19: 1368-1377.
24. Mungall, M.M. and Gaw, A. 2004. Statin therapy in the elderly. Curr. Opin. Lipidol. 15: 453-457.
25. Murakami, H., Okazaki, M., Amagasa, H., and Oguchi, K. 2003. Increase in hepatic mRNA expression of coagulant factors in type 2 diabetic model mice. Thromb. Res. 111: 81-87.
26. Ohta, S., Okazaki, M., Maruyama, M., and Oguchi, K. 2004. Involvement of IL-6 and IL-6 receptor in fibrinogen synthesis in the liver of Triton WR-1339-induced hyperlipidemic rats. In Vivo 18: 203-211.
27. Okazaki, M., Morio, Y., Iwai, S., Miyamoto, K., Sakamoto, H., Imai, K., and Oguchi, K. 1998. Age-related changes in blood coagulation and fibrinolysis in mice fed on high-cholesterol diet. Exp. Anim. 47: 237-246.
28. Okazaki, M., Suzuki, K., and Oguchi, K. 1990. Changes in coagulative and fibrinolytic activities in Triton WR-1339-induced hyperlipidemia in rats. Jpn. J. Pharmacol. 52: 353-361.
29. Russell, J.C., Koeslag, D.G., Dolphin, P.J., and Amy, R.M. 1993. Beneficial effects of acarbose in the atherosclerosis-prone JCR:LA-corpulent rat. Metabolism 42: 218-223.
30. Sawada, K., Naiki, M., Yago, H., Matsusita, K., Ohtsuki, T., Kitagawa, K., Matsumoto, M., and Hori, M. 2003. Hypertension associated with reduced plasma thrombomodulin levels and a hypercoagulable state in rats. Clin. Exp. Hypertens. 25: 73-84.
31. Wiegman, A., Hutten, B.A., de Groot, E., Rodenburg, J., Bakker, H.D., Büller, H.R., Sijbrands, E.J.G., and Kastelein, J.J.P. 2004. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. J.A.M.A. 292: 331-337.
32. Yudkin, J.S., Kumari, M., Humphries, S.E., and Mohamed-Ali, V. 2000. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148: 209-214.